Spectral AI, Inc. has announced a significant development in its financial strategy by entering into a Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD, a Cayman Islands exempt limited company known as Yorkville. This agreement allows Spectral AI to sell up to $15 million of its common stock, providing the company with a crucial funding mechanism as it navigates the competitive landscape of the surgical and medical instruments industry.

This SEPA, effective from November 13, 2026, amends a previous agreement made on March 19, 2024. The company retains the option to sell shares at its discretion, without any obligation to do so. This flexibility is vital for Spectral AI as it seeks to bolster its working capital and support ongoing operations.

Background

Spectral AI, Inc., listed on the Nasdaq under the ticker symbols MDAI and MDAIW, operates within the surgical and medical instruments and apparatus sector (SIC 3841). The company has been classified as an emerging growth company and a smaller reporting company, indicating its focus on innovation and growth in a rapidly evolving market. Recent filings include a 10-Q report and several Form 4 filings, highlighting ongoing activity in its financial management.

What the Filing Says

According to the filing, "On November 13, 2026, Spectral AI, Inc. entered into the Standby Equity Purchase Agreement with YA II PN, LTD, which amends the Standby Equity Purchase Agreement previously entered into on March 19, 2024." This agreement allows the company to sell shares of common stock, subject to certain conditions, providing it with financial flexibility to meet its operational needs.

Impact

The SEPA could have significant implications for Spectral AI and its stakeholders, including investors and employees. By securing this agreement, the company positions itself to access necessary funds without immediate pressure to sell shares, which could stabilize its stock price and support growth initiatives. Additionally, this move may inspire other companies in the surgical and medical instruments sector to explore similar funding arrangements.

What's Next

The filing does not specify what happens next beyond the execution of the SEPA. However, it indicates that the company will control the timing and amount of any sales of shares to Yorkville, which will depend on market conditions and other factors.